Showing results (111-120 of 151) with videos related to
Sort By:
Pageof 16
Journal of Clinical Hypertension (Greenwich, Conn.)|December 6, 2018
Predictors and correlates of systolic blood pressure reduction with liraglutide treatment in patients with type 2 diabetesMagnus O Wijkman, Mary Dena, Sofia Dahlqvist, et al.Journal of Diabetes Science and Technology|June 9, 2022
Evaluation of Effects of Continuous Glucose Monitoring on Physical Activity Habits and Blood Lipid Levels in Persons With Type 1 Diabetes Managed With Multiple Daily Insulin Injections: An Analysis Based on the GOLD Randomized Trial (GOLD 8)Thomas Nyström, Erik Schwarz, Sofia Dahlqvist, et al.Pediatric Diabetes|September 18, 2015
High hemoglobin A1c variability is associated with early risk of microalbuminuria in children with T1DSripriya Raman, Hongying Dai, Stephen A DeLurgio, et al.BMJ Open Diabetes Research & Care|April 1, 2021
Effects of nutrition education using a food-based approach, carbohydrate counting or routine care in type 1 diabetes: 12 months prospective randomized trialSofia Sterner Isaksson, Margareta Bensow Bacos, Björn Eliasson, et al.Diabetes, Obesity & Metabolism|May 31, 2019
Use of fast-acting insulin aspart in insulin pump therapy in clinical practiceMark Evans, Antonio Ceriello, Thomas Danne, et al.The Lancet Regional Health. Europe|October 27, 2025
Systematic intensive therapy in addition to continuous glucose monitoring in adults with type 1 diabetes: a multicentre, open-label, randomised controlled trialArndís F Ólafsdóttir, Kari-Anne Sveen, Magnus Wijkman, et al.Diabetes Care|November 17, 2020
Sustained Intensive Treatment and Long-term Effects on HbA1c Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDIMarcus Lind, Arndís F Ólafsdóttir, Irl B Hirsch, et al.Journal of Diabetes Science and Technology|July 28, 2023
Treatment Satisfaction and Well-Being With Continuous Glucose Monitoring in People With Type 1 Diabetes: An Analysis Based on the GOLD Randomized TrialDaniel Pylov, William Polonsky, Henrik Imberg, et al.Diabetes Technology & Therapeutics|April 3, 2018
A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3)Arndís F Ólafsdóttir, William Polonsky, Jan Bolinder, et al.World Journal of Diabetes|September 22, 2025
Increased tumor necrosis factor-receptor superfamily plasma levels are associated with early renal or retinal involvement in intermediate hyperglycemiaSebastian Mas-Fontao, Esther Civantos, Nisa Boukichou-Abdelkader, et al.Pageof 16